5 European Projects Found
Searched on 125080 European Projects
FINISHED
Persisting Transgenesis (PERSIST)
Start date: Jan 1, 2009, End date: Jun 30, 2013,
"For many disabling or fatal diseases, there is pre-clinical or clinical evidence of the potential therapeutic efficacy of gene therapy and, yet, the limitations of current gene transfer technologies have prevented success or even caused serious adverse events leading to termination of trials. PERSIST will explore the use of highly innovative gene-modifying and delivery technologies and capitalize ...
Read Project
29
Partners Participants
FINISHED
Defining regulators of hematopoietic stem cell homing and engraftment (HemHome)
Start date: Jul 1, 2010, End date: Feb 24, 2013,
Transplantation of hematopoietic stem cells (HSC) is a life-saving treatment for many serious diseases. Unfortunately, the procedure is often hampered by insufficient numbers of donor stem cells and attempts to expand HSCs ex vivo prior to transplantation have remained unsuccessful. An important alternative, which significantly would reduce the required number of donor cells, is to enhance the eng ...
Read Project
1
Partner Participant
FINISHED
Identification of novel factors to expand hematopoietic stem cells in vitro (NOVEXPAND)
Start date: Jan 1, 2011, End date: Dec 31, 2012,
"Blood and marrow transplantation (BMT) has been used successfully to treat malignant blood disorders and genetic diseases. Although BMT has been effective, problems remain, for example lack of suitable donors and engraftment failure. Cord blood (CB) contains hematopoietic stem cells (HSC) that can be used to transplant children. However, there are too few HSC in most CB samples to reliably engraf ...
Read Project
1
Partner Participant
FINISHED
Stem Cell Expansion - Expansion and engraftment of haematopoietic and mesenchymal stem cells (STEMEXPAND)
Start date: Nov 1, 2008, End date: Oct 31, 2011,
"Serious disorders of the blood system, particularly malignant blood disorders and genetic diseases can be effectively treated by blood and marrow transplantation. Despite considerable success with this treatment modality during the last decades, lack of suitable donors, engraftment failure and graft versus host disease remain serious problems that need to be addressed. This project aims to addres ...
Read Project
8
Partners Participants
FINISHED
A European Consortium for Lysosomal Disorders (EUCLYD)
Start date: May 1, 2008, End date: Apr 30, 2011,
"The EUCLYD consortium aims at developing a scientific network among outstanding communities of basic and clinical investigators in five European countries (Italy, Netherlands, UK, Sweden and Germany) to study various aspects of lysosomal storage diseases (LSD). LSDs are rare disorders (overall prevalence of 1/5000 to 1/8000), each due to a specific lysosomal enzyme deficiency, leading to intracel ...
Read Project
